Jim Cramer expressed optimism about Abbott Laboratories following a favorable jury verdict in a significant court case, which alleviates some litigation concerns surrounding its infant formula. The company, facing over a thousand claims related to necrotizing enterocolitis, saw its shares rise 4.61% after the jury found it not liable in the second trial. Cramer highlighted Abbott's strong fundamentals and core businesses, particularly in medical devices, and noted that the ruling could enhance Abbott's position in future cases and potential settlements.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.